BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37790699)

  • 1. Phenotype reversion as "natural gene therapy" in Fanconi anemia by a gene conversion event.
    Persico I; Fiscarelli I; Pelle A; Faleschini M; Pasini B; Savoia A; Bottega R
    Front Genet; 2023; 14():1240758. PubMed ID: 37790699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction.
    Gross M; Hanenberg H; Lobitz S; Friedl R; Herterich S; Dietrich R; Gruhn B; Schindler D; Hoehn H
    Cytogenet Genome Res; 2002; 98(2-3):126-35. PubMed ID: 12697994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells.
    Gregory JJ; Wagner JE; Verlander PC; Levran O; Batish SD; Eide CR; Steffenhagen A; Hirsch B; Auerbach AD
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2532-7. PubMed ID: 11226273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.
    Ramírez MJ; Pujol R; Trujillo-Quintero JP; Minguillón J; Bogliolo M; Río P; Navarro S; Casado JA; Badell I; Carrasco E; Balmaña J; Català A; Sevilla J; Beléndez C; Argilés B; López M; Díaz de Heredia C; Rao G; Nicoletti E; Schwartz JD; Bueren JA; Surrallés J
    Am J Hematol; 2021 Aug; 96(8):989-999. PubMed ID: 33984160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.
    Nicoletti E; Rao G; Bueren JA; Río P; Navarro S; Surrallés J; Choi G; Schwartz JD
    Ann Hematol; 2020 May; 99(5):913-924. PubMed ID: 32065290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.
    Soulier J; Leblanc T; Larghero J; Dastot H; Shimamura A; Guardiola P; Esperou H; Ferry C; Jubert C; Feugeas JP; Henri A; Toubert A; Socié G; Baruchel A; Sigaux F; D'Andrea AD; Gluckman E
    Blood; 2005 Feb; 105(3):1329-36. PubMed ID: 15383454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia.
    Krausz C; Riera-Escamilla A; Chianese C; Moreno-Mendoza D; Ars E; Rajmil O; Pujol R; Bogliolo M; Blanco I; Rodríguez I; Badell I; Ruiz-Castañé E; Surrallés J
    Genet Med; 2019 Jan; 21(1):189-194. PubMed ID: 29904161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism.
    Waisfisz Q; Morgan NV; Savino M; de Winter JP; van Berkel CG; Hoatlin ME; Ianzano L; Gibson RA; Arwert F; Savoia A; Mathew CG; Pronk JC; Joenje H
    Nat Genet; 1999 Aug; 22(4):379-83. PubMed ID: 10431244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.
    Lo Ten Foe JR; Kwee ML; Rooimans MA; Oostra AB; Veerman AJ; van Weel M; Pauli RM; Shahidi NT; Dokal I; Roberts I; Altay C; Gluckman E; Gibson RA; Mathew CG; Arwert F; Joenje H
    Eur J Hum Genet; 1997; 5(3):137-48. PubMed ID: 9272737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-repair history: compensatory effect of a
    Persico I; Fontana G; Faleschini M; Zanchetta ME; Ammeti D; Cappelli E; Corsolini F; Mosa C; Guarina A; Bogliolo M; Surrallés J; Dufour C; Farruggia P; Savoia A; Bottega R
    Front Genet; 2023; 14():1209138. PubMed ID: 37547463
    [No Abstract]   [Full Text] [Related]  

  • 12. Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic
    Lach FP; Singh S; Rickman KA; Ruiz PD; Noonan RJ; Hymes KB; DeLacure MD; Kennedy JA; Chandrasekharappa SC; Smogorzewska A
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33172906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.
    Virts EL; Jankowska A; Mackay C; Glaas MF; Wiek C; Kelich SL; Lottmann N; Kennedy FM; Marchal C; Lehnert E; Scharf RE; Dufour C; Lanciotti M; Farruggia P; Santoro A; Savasan S; Scheckenbach K; Schipper J; Wagenmann M; Lewis T; Leffak M; Farlow JL; Foroud TM; Honisch E; Niederacher D; Chakraborty SC; Vance GH; Pruss D; Timms KM; Lanchbury JS; Alpi AF; Hanenberg H
    Hum Mol Genet; 2015 Sep; 24(18):5093-108. PubMed ID: 26085575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
    Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
    Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
    Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Fanconi anemia in patients with bone marrow failure.
    Pinto FO; Leblanc T; Chamousset D; Le Roux G; Brethon B; Cassinat B; Larghero J; de Villartay JP; Stoppa-Lyonnet D; Baruchel A; Socié G; Gluckman E; Soulier J
    Haematologica; 2009 Apr; 94(4):487-95. PubMed ID: 19278965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.
    Solomon PJ; Margaret P; Rajendran R; Ramalingam R; Menezes GA; Shirley AS; Lee SJ; Seong MW; Park SS; Seol D; Seo SH
    Ital J Pediatr; 2015 May; 41():38. PubMed ID: 25953249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.